{
    "@context": "https://schema.org/",
    "@type": "Dataset",
    "_id": "sdy3016",
    "_ignored": [
        "all.keyword"
    ],
    "_score": 10.858765,
    "abstract": "Whole transcriptome analysis using RNA seq of whole blood were perfomed and serological status assessed via HAI. Using forest computational model, investigators analyzed gene expression and vaccine response prediction.",
    "author": [
        {
            "@type": "Person",
            "affiliation": {
                "name": "Icahn School of Medicine at Mount Sinai"
            },
            "name": "Christian Forst"
        }
    ],
    "citedBy": [
        {
            "@type": "ScholarlyArticle",
            "doi": "10.3390/v14112446",
            "name": "Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes.",
            "pmid": "36366544",
            "url": "https://pubmed.ncbi.nlm.nih.gov/36366544"
        }
    ],
    "conditionsOfAccess": "Closed",
    "curatedBy": {
        "@type": "Organization",
        "name": "ImmPort Data Curation Team"
    },
    "date": "2025-04-24",
    "dateModified": "2025-04-24T00:00:00",
    "description": "A number of factors influence vaccination effectiveness, including age, sex, and comorbidities. A transcriptome analysis was performed via RNA sequencing. The genes with immunological functions are increased in expression in individuals with high pre-existing immunity. Based on the transcriptome analysis, the set of genes can be used to predict a vaccine response.",
    "distribution": [
        {
            "@type": "DataDownload",
            "contentUrl": "https://browser.immport.org/browser?path=SDY3016",
            "dateModified": "2025-04-24T00:00:00",
            "encodingFormat": "URL"
        }
    ],
    "doi": "10.21430/M3KA9EZEP8",
    "funding": [
        {
            "endDate": "2020-09-09",
            "funder": [
                {
                    "alternateName": [
                        "National Institute of Allergy & Infectious Diseases",
                        "NIAID",
                        "Instituto Nacional de Alergias y Enfermedades Infecciosas"
                    ],
                    "identifier": "https://ror.org/043z4tv69",
                    "name": "National Institute of Allergy and Infectious Diseases",
                    "parentOrganization": "National Institutes of Health"
                }
            ],
            "identifier": "75N93019C00052-0-9999-1",
            "name": "CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations",
            "startDate": "2019-09-10",
            "url": "https://reporter.nih.gov/project-details/10021763"
        },
        {
            "funder": {
                "@type": "Organization",
                "alternateName": [
                    "National Institute of Allergy & Infectious Diseases",
                    "NIAID",
                    "Instituto Nacional de Alergias y Enfermedades Infecciosas"
                ],
                "identifier": "https://ror.org/043z4tv69",
                "name": "National Institute of Allergy and Infectious Diseases",
                "parentOrganization": "National Institutes of Health"
            }
        }
    ],
    "healthCondition": [
        {
            "alternateName": [
                "influenza with non-respiratory manifestation",
                "orthomyxoviridae caused disease or disorder",
                "Influenza with other manifestations",
                "orthomyxoviridae disease or disorder",
                "flu",
                "influenza infection",
                "orthomyxoviridae infectious disease"
            ],
            "identifier": "0005812",
            "inDefinedTermSet": "MONDO",
            "isCurated": true,
            "name": "influenza",
            "originalName": "influenza",
            "url": "http://purl.obolibrary.org/obo/MONDO_0005812"
        }
    ],
    "identifier": [
        "10.21430/M3KA9EZEP8"
    ],
    "includedInDataCatalog": {
        "@type": "DataCatalog",
        "archivedAt": "https://immport.org/shared/study/SDY3016",
        "name": "ImmPort",
        "url": "https://immport.org",
        "versionDate": "2025-04-24T00:00:00"
    },
    "isAccessibleForFree": true,
    "isBasedOn": [
        {
            "additionalType": {
                "name": "Bio Sample Preparation"
            },
            "description": "Protocol for preparing RNA extracted from whole blood for sequencing",
            "identifier": "PTL12639",
            "name": "NEBNext_Ultra_II_Protocol_E7775.pdf",
            "url": "https://www.immport.org/browser/?path=SDY3016"
        }
    ],
    "keywords": [
        "CIVICs Collaborative Influenza Vaccine Innovation Centers",
        "Differential expression will be determined using edgeR, with differentially expressed genes defined as those with adjusted p value less than 0.05. Vaccine response will be defined as the magnitude of change in HAI between day 0 and day 28. Out-of-bag error rate and area-under-the-curve analyses are used to identify prediction success of the random forest model."
    ],
    "license": "https://www.immport.org/agreement",
    "name": "Vaccination History, BMI, Age and Gene Expression Predict Influenza Vaccination Outcomes",
    "sameAs": "https://doi.org/10.21430/M3KA9EZEP8",
    "sourceOrganization": [
        {
            "@type": "ResearchProject",
            "abstract": "Collaborative Influenza Vaccine Innovation Centers (CIVICs) is a network of research centers working collaboratively to develop next-generation influenza vaccines. Their goal is to create vaccines that provide broader, longer-lasting protection against influenza viruses.",
            "alternateName": [
                "CIVIC",
                "Collaborative Influenza Vaccine Innovation Centers",
                "CIVICs"
            ],
            "correctionApproved": true,
            "description": "Collaborative Influenza Vaccine Innovation Centers (CIVICs) is a network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines. For more information, visit the NIAID program page: https://www.niaid.nih.gov/research/civics",
            "name": "NIAID CIVICs Network",
            "parentOrganization": [
                "NIAID"
            ],
            "url": "https://www.niaidcivics.org/"
        }
    ],
    "species": [
        {
            "alternateName": [
                "Human",
                "Homo sapiens Linnaeus, 1758",
                "human",
                "Home sapiens",
                "Homo sampiens",
                "Homo sapeins",
                "Homo sapian",
                "Homo sapians",
                "Homo sapien",
                "Homo sapience",
                "Homo sapiense",
                "Homo sapients",
                "Homo sapines",
                "Homo spaiens",
                "Homo spiens",
                "Humo sapiens"
            ],
            "classification": "host",
            "commonName": "Human",
            "curatedBy": {
                "dateModified": "2023-10-05",
                "name": "PubTator",
                "url": "https://www.ncbi.nlm.nih.gov/research/pubtator/api.html"
            },
            "displayName": "Human | Homo sapiens",
            "identifier": "9606",
            "inDefinedTermSet": "UniProt",
            "isCurated": true,
            "name": "Homo sapiens",
            "originalName": "homo sapiens",
            "url": "https://www.uniprot.org/taxonomy/9606"
        }
    ],
    "url": "https://immport.org/shared/study/SDY3016"
}